Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Chest Med. 2004 Mar;25(1):113-22.

Drug-induced airway diseases.

Author information

1
Mail Point 810, Level D, Centre Block, Southampton General Hospital, Southampton SO16 6YD, UK. ksb@soton.ac.uk

Abstract

Drug-induced airway disease is a significant problem and must be considered in the differential diagnosis. A history of drug intake with a temporal association should raise the physician's suspicion toward a drug-induced cause. Because most of the conditions are amenable to withdrawal of the offending agent, an early diagnosis is essential. Conditions like obliterative bronchiolitis, are usually irreversible, but timely stoppage of the provoking agent can prevent further progression of the disease. Most of the drug reactions are nonallergic and the physician and the patient should be aware of this fact. In view of the constantly-evolving therapies, an active policy to identify and report adverse effects is essential to develop management strategies and treatment recommendations.

PMID:
15062603
DOI:
10.1016/S0272-5231(03)00136-9
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center